文献速递妇科

受miR-30c调控的转移相关蛋白1通过AKT/mTOR/4E-BP1通路促进子宫内膜癌进展

Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
PubMed 文献 · Gynecol Oncol · 2019-04-09

研究分析MTA1在子宫内膜癌组织与细胞中的表达及功能,发现MTA1在癌组织表达显著高于正常子宫内膜,与淋巴结转移和不良生存正相关;过表达MTA1促进癌细胞增殖、迁移、侵袭和体内肿瘤生长,并逆转miR-30c的负向调控,伴随AKT/mTOR/4E-BP1通路磷酸化改变,提示MTA1可能为潜在治疗靶点。

要点

  • MTA1在子宫内膜癌组织表达显著高于正常子宫内膜,与淋巴结转移和不良生存率正相关。
  • 过表达MTA1促进Ishikawa、HEC-1B、RL-952细胞增殖、迁移、侵袭,敲低则抑制。
  • MTA1可逆转miR-30c对子宫内膜癌细胞的负向作用,并伴随AKT/mTOR/4E-BP1磷酸化改变。

核心结论

  • MTA1作为miR-30c的下游靶点,可能通过AKT/mTOR/4E-BP1通路促进子宫内膜癌进展,提示MTA1是子宫内膜癌的潜在治疗靶点。

研究设计与样本

  • 采用蛋白质印迹和免疫组化分析细胞与组织蛋白表达,实时PCR检测RNA,生物信息学工具分析MTA1与临床病理特征及生存的关系。
  • 采用CCK-8、集落形成、细胞划痕和Transwell实验分别测定细胞增殖、迁移和侵袭能力。
  • 在子宫内膜癌细胞系Ishikawa、HEC-1B和RL-952中进行MTA1过表达与敲低实验,并在体内外检测AKT/mTOR/4E-BP1通路磷酸化变化。

主要发现

  • MTA1在人子宫内膜癌组织中的表达水平显著高于正常子宫内膜。
  • MTA1表达与子宫内膜癌淋巴结转移和不良生存率呈正相关。
  • 过表达MTA1促进Ishikawa、HEC-1B和RL-952细胞的增殖、迁移和侵袭能力,降低MTA1则抑制这些细胞生物学行为。
  • MTA1可逆转其直接调控因子miR-30c对子宫内膜癌细胞的负向作用。
  • 过表达MTA1促进子宫内膜癌肿瘤生长,敲低MTA1则抑制肿瘤生长;体内外实验中mTOR(S2448)和4E-BP1(T37/46)磷酸化水平随AKT(T308)在MTA1调控下发生显著变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Though metastasis-associated protein 1 (MTA1) is widely overexpressed in human cancers and is associated with advanced clinicopathological characteristics and survival in related diseases, the association between MTA1 and endometrial cancer (EC) is little known and needs to be studied. METHODS: Western blot and immunohistochemistry were used to analyze protein expression level of cells and tissues, while real-time PCR was used for RNA detection. Bioinformatics tool analysis revealed the relationship between MTA1 and clinicopathological characteristics and survival. CCK-8 assay, colony-formation assay, cell scratch assay, and Transwell assay were performed to determine cell proliferation, migration and invasion abilities, respectively. RESULTS: The expression level of MTA1 was significantly higher in human EC tissues than in normal endometrium. MTA1 expression was correlated positively with lymph nodes metastasis and poor survival rate in EC. Experimentally overexpressed MTA1 could promote cell proliferation, migration and invasion abilities of EC cell lines Ishikawa, HEC-1B, and RL-952, while reduction of MTA1 inhibited these cell biological behaviors. Moreover, MTA1 could also reverse the negative effect of miR-30c, a direct modulator of MTA1, on EC cells. Our research also revealed that overexpression of MTA1 contributed to EC tumor growth, while knockdown of MTA1 resulted in tumor growth inhibition. Additionally, the phosphorylation levels of mTOR (S2448) and 4E-BP1 (T37/46) changed significantly along with AKT (T308) under regulation of MTA1, both in vivo and vitro. CONCLUSION: Our results showed that MTA1, as a downstream target of miR-30c, might promote EC progression via AKT/mTOR/4E-BP1 pathway, which indicated the potential therapy target of MTA1 in EC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Xu X, Kong X, Liu T, et al. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway. Gynecol Oncol. 2019. PMID: 30979588. doi:10.1016/j.ygyno.2019.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。